Takeda
company
Investments
Number of Investments
Number of Lead Investments
43
13
Takeda has made 43 investments. Their most recent investment was on
Apr 19, 2022, when Hedge, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Apr 19, 2022 | Hedge | Seed | — | Blockchain | — |
| Dec 21, 2021 | Ambys Medicines | Series A | — | Biotechnology | — |
| Oct 27, 2021 | Cardurion Pharmaceuticals | Series B | — | Biotechnology | — |
| Nov 13, 2020 | Bridge Medicines | Series Unknown | — | Pharmaceutical | — |
| Oct 6, 2020 | xFOREST Therapeutics | Seed | — | Biotechnology | Yes |
| Jun 25, 2020 | ENTEROME | Series E | — | Biopharma | — |
| Dec 19, 2019 | Turnstone Biologics | Corporate Round | — | Biotechnology | Yes |
| May 9, 2019 | Printify | Seed | — | E-Commerce | — |
| Oct 17, 2018 | Avidity Biosciences | Series B | — | Biotechnology | Yes |
| Aug 8, 2018 | Ambys Medicines | Corporate Round | — | Biotechnology | — |
| Jul 17, 2018 | GEXVal | Series A | — | Emergency Medicine | Yes |
| Jun 25, 2018 | Reborna Biosciences | Seed | — | Biotechnology | Yes |
| Apr 1, 2018 | Fimecs | Seed | — | Biotechnology | — |
| Feb 21, 2018 | Cerevance | Series Unknown | — | Biotechnology | — |
| Nov 23, 2017 | Chordia Therapeutics | Series A | — | Health Diagnostics | Yes |
| Sep 4, 2017 | Noile-Immune Biotech | Corporate Round | — | Biotechnology | Yes |
| Aug 16, 2017 | Molecular Templates | Post-IPO Equity | — | Biotechnology | — |
| May 3, 2017 | Cerevance | Series A | — | Biotechnology | — |
| Mar 14, 2017 | Scohia Pharma | Corporate Round | — | Biotechnology | — |
| Mar 5, 2017 | Helpmum | Grant | — | Health Care | — |
| Jan 5, 2017 | PvP Biologics | Series Unknown | — | Biotechnology | Yes |
| Jan 1, 2017 | Maverick Therapeutics | Series Unknown | — | Biotechnology | — |
| Dec 2, 2016 | Cerevance | Series A | — | Biotechnology | Yes |
| Oct 31, 2016 | Bridge Medicines | Series Unknown | — | Pharmaceutical | Yes |
| Oct 20, 2016 | EllieGrid | Grant | — | Analytics | — |
| Jun 16, 2016 | Mersana Therapeutics | Series C | — | Biotechnology | — |
| Jun 7, 2016 | Ultragenyx Pharmaceutical | Post-IPO Equity | — | Biotechnology | — |
| Mar 14, 2016 | Outpost Medicine | Series A | — | Biopharma | — |
| Dec 21, 2015 | Aquinnah Pharmaceuticals | Series Unknown | — | Health Care | Yes |
| Feb 25, 2015 | Airtable | Seed | — | Collaboration | — |
| May 6, 2014 | Naurex | Series C | — | Biopharma | — |
| Jan 17, 2014 | Seagen | Post-IPO Equity | — | Biotechnology | — |
| Oct 15, 2013 | Keepy | Seed | — | Lifestyle | — |
| Jul 26, 2013 | Zenefits | Seed | — | Health Insurance | — |
| Jan 30, 2013 | Lyft | Series B | — | Apps | — |
| Jun 6, 2012 | Indiegogo | Series A | — | Crowdfunding | — |
| May 14, 2012 | Quora | Series B | — | Information Services | — |
| May 1, 2012 | Pindrop | Seed | — | Audio | — |
| Jan 1, 2012 | Lever | Seed | — | CRM | — |
| Mar 28, 2011 | Alnylam Pharmaceuticals | Post-IPO Equity | — | Biotechnology | Yes |
| Mar 23, 2011 | Sosh | Seed | — | Apps | — |
| Sep 18, 2006 | Xenon Pharmaceuticals | Private Equity（PE） | — | Biopharma | — |
| Oct 8, 2004 | BioNumerik Pharmaceuticals | Corporate Round | — | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
